WHO statement: Can't say whether Russian vaccine can be used on a large scale, we don't have much information yet

Posted on 14th Aug 2020 by rohit kumar

The World Health Organization (WHO) has made a big statement on Sputnik-V, a Russian vaccine surrounded by questions. The WHO said the vaccine that Russia claimed to have made has not been tested in advance stage. It is not included in the 9 vaccines in the world, which is undergoing advanced stage trials.

 

"There is not enough information yet to decide whether the Covid-19 vaccine manufactured in Russia can be used on a large scale," World Health Organization Director-General Tedros Adhanom said in a press conference.

 

Talks continue to know the status of the vaccine

 

Dr. Bruce Elward, WHO's Senior Advisor on Russia's Vaccine, says, "We don't have enough information about it to make a decision." We are in discussion with Russia for more information about the vaccine. Talks are on to find out the status of the vaccine.

 

Tedros warned that the demand for safe and effective vaccines has increased competition among countries, raising the price of vaccines. This can increase vaccine prices. He appealed to various countries to provide more funds for the 'ACT Accelerator' scheme, so that equipment connected to Covid-19 can be distributed.

 

Vaccine registration documents expand the scope of questions

 

The Russian vaccine Sputnik-V is being questioned worldwide. There have been many revelations from documents presented during the registration of the world's first corona vaccine on 11 August. According to the documents, there was no complete clinical study to know how safe the vaccine is.

 

According to the news of the Daily Mail, only 38 volunteers were given vaccine doses in the name of trial in 42 days. No information has been revealed on the third phase of the trial.

 

The Russian government claimed that there were no side effects of the vaccine, while documents show that 144 types of side effects have been seen in 38 volunteers. Even on the 42nd day of the trial, 31 out of 38 volunteers were seen struggling with these side effects. Volunteers had many difficulties after taking the dose.

 

Not only WHO, experts from all over the world are raising questions

 

Before the registration of the Russian vaccine, the experts there had feared its safety and side effects. Moscow's Association of Clinical Trial Organizations (ACTO) wrote a letter to the Ministry of Health.

 

According to Svetlana Javidova, executive director of the Moscow Association of Clinical Trial Organizations, why all corporations are following the rules but not the people of Russia? Clinical trial guidelines are in our blood, which can never be changed. What will happen after any unproven vaccine is put to humans, we do not know.

 

WHO has stated that Russia has not followed the guidelines set forth to make the vaccine, so it is difficult to trust the success and safety of this vaccine. Many guidelines have been made for vaccine production, which the teams are also doing this, they have to follow it.

 

It is shameful for Russia to do this, says Professor Francia Ballux of University College London. This is a very poor decision. It is wrong to give vaccines to people on a large scale, ignoring the trial guidelines. It will have a bad effect on human health.

 

According to Germany's Health Minister Jens Spahn, the Russian vaccine was not adequately investigated. Giving it to people can prove dangerous. First of all, it is more important to be safe.

 

Questioning the vaccine, America's top infectious disease specialist, Dr. Anthony Focky, said, "Preparing to distribute the vaccine without a trial can further exacerbate the problem." In an interview with National Geographic, Dr. Anthony said, "I hope that Russia has got the vaccine certified and it proves safe."

 

According to American Health and Human Secretary Alex Ager, the most important thing is that every data related to the vaccine is transparent. This will prove how safe the vaccine is and whether people will be able to save the disease.

Other news